Brief: Tenax Announces Successful Comparative Pharmacokinetic Study Of Pulmonary Arterial Hypertension Treatment
23/05/2022 14:11
May 23 (Reuters) - Tenax Therapeutics Inc TENX.O :
* TENAX THERAPEUTICS ANNOUNCES SUCCESSFUL COMPARATIVE
PHARMACOKINETIC STUDY OF TNX-201 FOR THE TREATMENT OF PULMONARY
ARTERIAL HYPERTENSION
* TENAX THERAPEUTICS INC - MANUFACTURING UNDERWAY TO SUPPORT
PHASE
3 PAH STUDY (IMPROVE)
* TENAX THERAPEUTICS INC - CLINICAL SITES ARE NOW BEING
RECRUITED,
WITH PATIENT ENROLMENT EXPECTED TO START IN 2H 2022
Source text for Eikon: ID:nBw5TV3Yka
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))